The influence of mPEG-PCL and mPEG-PLGA on encapsulation efficiency and drug-loading of SN-38 NPs

References

• Allen C, Maysinger D, Eisenberg A. 1999. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces. 16:3–27.
   Web of Science ®Google Scholar
• An D, Zhao X, Ye Z. 2015. Enzymatic synthesis and characterization of galactosyl monoesters. Carbohydr Res. 414:32–38.
   PubMed Web of Science ®Google Scholar
• Anari E, Akbarzadeh A, Zarqhami N. 2015. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell Line. Artif Cells Nanomed Biotechnol. 6:1–7.
   Web of Science ®Google Scholar
• Atyabi F, Farkhondehfai A, Esmaeili F, Dinarvand R. 2009. Preparation of pegylated nano-liposomal formulation containing SN-38: in vitro characterization and in vivo biodistribution in mice. Acta Pharm. 59:133–144.
   PubMed Web of Science ®Google Scholar
• Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. 2008. Emerging nanopharmaceuticals. Nanomedicine: NBM. 4:273–282.
   PubMed Web of Science ®Google Scholar
• Chabner BA, Longo DL. 2001. Cancer Chemotherapy and Biotherapy: Principles and Practice. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, pp. 579–646.
   Google Scholar
• Chen JN, Li SS, Shen Q, He H, Zhang Y. 2011. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Drug Dev Ind Pharm. 37:1339–1346.
   PubMed Web of Science ®Google Scholar
• Crow RT, Crothers DM. 1992. Structural modifications of camptothecin and effects on topoisomerase I inhibition. J Med Chem. 35:4160–4164.
   PubMed Web of Science ®Google Scholar
• Diab R, Hamoudeh M, Boyron O, Elaissari A, Fessi H. 2010. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents. Drug Dev Ind Pharm. 36:456–469.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad P, Dinarvand R, Jafari MR, Tabasi SA, Atyabi F. 2011. Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38. Int J Pharm. 406:122–127.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad P, Dinarvand R, Sajadi A, Jaafari MR, Nomani AR, Azizi E, Rad-Malekshahi M, Atyabi F. 2010. Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT29 cell lines. Nanomedicine: NBM. 6:478–485.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad P, Dinarvand R, Sajadi SA, Atyabi F, Ramezani F, Jaafari MR. 2009. Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38. PDA J Pharm Sci Technol. 63:512–520.
   PubMedGoogle Scholar
• Fu XN, Luan LB. 2008. Preparation of long-circulated liposome containing 7-ethyl-10-hydroxycamptothecin and its pharmacokinetic study. Chin New Drugs J. 17:2132–2136.
   Google Scholar
• Gu Q, Xing JZ, Huang M, He C, Chen J. 2012. SN-38 loaded polymeric micelles to enhance cancer therapy. Nanotechnology. 23:205101.
   PubMed Web of Science ®Google Scholar
• Hsiang YH, Hertzberg R, Hecht S, Liu LF. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 260:14873–14878.
   PubMed Web of Science ®Google Scholar
• Hurter PN, Scheutijens JMHM, Hatton TA. 1993. Molecular modeling of micelle formation and solubilization in block copolymer micelles. 1. A self-consistent mean-field lattice theory. Macromolecules. 26:5592–5601.
   Web of Science ®Google Scholar
• Kozlov MY, Melik-Nubarov NS, Batrakova EV, Kabanov AV. 2000. Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules. 33:3305–3313.
   Web of Science ®Google Scholar
• Kunii R, Onishi H, Ueki K, Koyama K, Machida Y. 2008. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles. Drug Deliv. 15:3–10.
   PubMed Web of Science ®Google Scholar
• Lee ES, Na K, Bae YH. 2003. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release. 91:103–113.
   PubMed Web of Science ®Google Scholar
• Li R, Li X, Xie L, Ding D, Hu Y, Qian X, et al. 2009. Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery. Int J Pharm. 379:158–166.
   PubMed Web of Science ®Google Scholar
• Liu J, Lee H, Allen C. 2006. Formulation of drugs in block copolymer micelles: Drug loading and release. Curr Pharm Design. 12:4685–4701.
   PubMed Web of Science ®Google Scholar
• Pal A, Khan S, Wang YF, Kamath N, Sarkar AK, Ahmad A, et al. 2005. Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation. Anticancer Res. 25:331–342.
   PubMed Web of Science ®Google Scholar
• Patel S, Lavasanifar A, Choi P. 2008. Application of molecular dynamics simulation to predict the compatability between water-insoluble drugs and self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymers. Biomacromolecules. 9:3014–3023.
   PubMed Web of Science ®Google Scholar
• Prasad S, Danqi JS. 2015. Development and characterization of pH responsive polymeric nanoparticles of SN-38 for colon cancer. Artif Cells Nanomed Biotechnol. 5:1–11.
   Web of Science ®Google Scholar
• Satoh T, Hosokawa M, Atsumi R, Suzuki W, Hakusui H, Nagai E. 1994. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. Biol Pharm Bull. 17:662–664.
   PubMed Web of Science ®Google Scholar
• Shuai X, Ai H, Nasongkla N, Kim S, Gao J. 2004b. Micellar carriers based on block copolymers of poly(ɛ-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release. 98:415–426.
   PubMed Web of Science ®Google Scholar
• Shuai X, Merdan T, Schaper AK, Xi F, Kissel T. 2004a. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug Chem. 15:441–448.
   PubMed Web of Science ®Google Scholar
• Slatter JG, Su P, Sams JP, Schaaf LJ, Wienkers LC. 1997. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. Drug Metab Dispos. 25:1157–1164.
   PubMed Web of Science ®Google Scholar
• Valizadeh A, Bakhtiary M, Akbarzadeh A, Salehi R, Frakhani SM, Ebrahimi O, Rahmati-Yamchi M, Davaran S. 2016. Preparation and characterization of novel electrospun poly(ε-caprolactone)-based nanofibrous scaffolds. Artif Cells Nanomed Biotechnol. 44:504–509.
   PubMed Web of Science ®Google Scholar
• Vangara KK, Liu JL, Palakurthi S. 2013. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer Res. 33:2425–2434.
   PubMed Web of Science ®Google Scholar
• Wadkins RM, Potter PM, Vladu B, Marty J, Mangold G, Weitman S, et al. 1999. Water soluble 20(s)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts. Cancer Res. 59:3424–3428.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu T, Lin R, Liu B, Yang G, Bu X, et al. 2014. Preparation and in vitro release of buccal tablets of naringenin-loaded MPEG-PCL nanoparticles. RSC Adv. 4:33672–33679.
   Web of Science ®Google Scholar
• Wang Y, Guo M, Lu Y, Ding L, Yu S. 2013. PLGA nanoparticles containing SN-38 for reversing multiple drug resistance of A549/DDP cells. J Control Release. 172:e67.
   Web of Science ®Google Scholar
• Wani MC, Nicholas AW, Manikumar G, Wall ME. 1987. Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogues. Structure-activity correlations. J Med Chem. 30:1774–1779.
   PubMed Web of Science ®Google Scholar
• Wen R, Li H, Du S, Zhao X, Zhao Z, Bai J, Lu Y. 2014. Preparation of mPEG2000-PLA-modified Xingnaojing microemulsion and evaluation in mucosal irritation. J Biomater Sci Polym Ed. 25:923–942.
   PubMed Web of Science ®Google Scholar
• Williams CC, Thang SH, Hantke T, Vogel U, Seeberger PH, Tsanaktsidis J, Lepenies B. 2012. RAFT-derived polymer–drug conjugates: Poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates. Chem Med Chem. 7:281–291.
   Web of Science ®Google Scholar
• Xie W, Zhu W, Shen Z. 2007. Synthesis, isothermal crystallization and micellization of mPEG-PCL diblock copolymers catalyzed by yttrium complex. Polymer. 48:6791–6798.
   Web of Science ®Google Scholar
• Yang B, Lowe JP, Schweins R, Edler KJ. 2015. Small angle neutron scattering studies on the internal structure of poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles as drug delivery vehicles. Biomacromolecules. 16:457–464.
   PubMed Web of Science ®Google Scholar
• Zhang JA, Xuan T, Ma M, Ma L, Ugwu S, Ali S, Ahmad I. 2004. Development and characterization of a novel liposome-based formulation of SN-38. Int J Pharm. 270:93–107.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zeng W, Xu H, Yi G. 2014. Synthesis and self-assembly of amphiphilic diblock copolymer poly(N-vinylpyrrolidone)-b-poly(ɛ-caprolactone). Polym Materials Sci Eng. 30:11–15.
   Google Scholar
• Zhao H, Rubio B, Sapra P, Wu D, Reddy P, Sai P, et al. 2008. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers. Bioconjugate Chem. 19:849–859.
   PubMed Web of Science ®Google Scholar
• Zheng D, Liu H, Gong T, Zhang ZR. 2014. Preparation, pharmacokinetics and toxicity studies of lipid albumin nanoparticle loaded with 7-ethyl-10-hydroxycamptothecin. West China J Pharm Sci. 29:497–499.
   Google Scholar